Cargando…

Rates of glycaemic deterioration in a real-world population with type 2 diabetes

AIMS/HYPOTHESIS: There is considerable variability in how diabetes progresses after diagnosis. Progression modelling has largely focused on ‘time to failure’ methods, yet determining a ‘coefficient of failure’ has many advantages. We derived a rate of glycaemic deterioration in type 2 diabetes, usin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Donnelly, Louise A., Zhou, Kaixin, Doney, Alex S. F., Jennison, Chris, Franks, Paul W., Pearson, Ewan R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448965/ https://www.ncbi.nlm.nih.gov/pubmed/29260253 http://dx.doi.org/10.1007/s00125-017-4519-5

Ejemplares similares

Identification of biomarkers for glycaemic deterioration in type 2 diabetes
por: Slieker, Roderick C., et al.
Publicado: (2023)

Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: rationale and design of the epidemiological studies within the IMI DIRECT Consortium
por: Koivula, Robert W., et al.
Publicado: (2014)

Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis
por: Zhou, Kaixin, et al.
Publicado: (2014)

Characteristics of people with high visit‐to‐visit glycaemic variability in Type 2 diabetes
por: Noyes, J. D., et al.
Publicado: (2017)

Age at diagnosis predicts deterioration in glycaemic control among children and adolescents with type 1 diabetes
por: Clements, Mark A, et al.
Publicado: (2014)

Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium
por: Koivula, Robert W., et al.
Publicado: (2019)

Evidence-based prioritisation and enrichment of genes interacting with metformin in type 2 diabetes
por: Dawed, Adem Y., et al.
Publicado: (2017)

The Health Economic Value of Changes in Glycaemic Control, Weight and Rates of Hypoglycaemia in Type 1 Diabetes Mellitus
por: McEwan, Phil, et al.
Publicado: (2016)

Personalised Nutritional Recommendations Based on Individual Post-Prandial Glycaemic Responses Improve Glycaemic Metrics and PROMs in Patients with Type 2 Diabetes: A Real-World Assessment
por: Ungersboeck, Madlen, et al.
Publicado: (2022)

The impact of birthweight on subsequent phenotype of type 2 diabetes in later life
por: Paulina, Christian, et al.
Publicado: (2022)

Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents
por: Dawed, Adem Yesuf, et al.
Publicado: (2016)

Low carbohydrate diet and improved glycaemic control in a patient with type one diabetes
por: Eiswirth, Mirjam, et al.
Publicado: (2018)

TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol
por: Angwin, Catherine, et al.
Publicado: (2020)

Adult‐onset type 1 diabetes: Predictors of glycaemic control
por: Hesse, Dan, et al.
Publicado: (2018)

Associations of the HOMA2‐%B and HOMA2‐IR with progression to diabetes and glycaemic deterioration in young and middle‐aged Chinese
por: Fan, Baoqi, et al.
Publicado: (2022)

Reduced-Function SLC22A1 Polymorphisms Encoding Organic Cation Transporter 1 and Glycemic Response to Metformin: A GoDARTS Study
por: Zhou, Kaixin, et al.
Publicado: (2009)

Physical Activity, but Not Glycaemic Load, Is Associated with Lower Real-Time Glycaemic Control in Free-Living Women with Gestational Diabetes Mellitus
por: Jardine, Isabelle R., et al.
Publicado: (2023)

Acute kidney injury, plasma lactate concentrations and lactic acidosis in metformin users: A GoDarts study
por: Connelly, Paul J., et al.
Publicado: (2017)

Costs and Treatment Pathways for Type 2 Diabetes in the UK: A Mastermind Cohort Study
por: Eibich, Peter, et al.
Publicado: (2017)

Gene-Environment and Gene-Treatment Interactions in Type 2 Diabetes: Progress, pitfalls, and prospects
por: Franks, Paul W., et al.
Publicado: (2013)

Persistent poor glycaemic control in individuals with type 2 diabetes in developing countries: 12 years of real-world evidence of the International Diabetes Management Practices Study (IDMPS)
por: Aschner, Pablo, et al.
Publicado: (2020)

Interaction between variants in the CYP2C9 and POR genes and the risk of sulfonylurea‐induced hypoglycaemia: A GoDARTS Study
por: Dujic, Tanja, et al.
Publicado: (2017)

Glycaemic Control in People with Type 2 Diabetes Treated with Insulin Degludec: A Real-World, Prospective Non-interventional Study—UPDATES Saudi Arabia
por: AlMalki, Mussa H., et al.
Publicado: (2022)

Clinical effectiveness of liraglutide vs basal insulin in a real‐world setting: Evidence of improved glycaemic and weight control in obese people with type 2 diabetes
por: Overbeek, Jetty A., et al.
Publicado: (2018)

Glycaemic and non‐glycaemic efficacy of once‐weekly GLP‐1 receptor agonists in people with type 2 diabetes
por: Patel, Dhiren
Publicado: (2020)

Glycaemic control in diabetic patients in Zambia
por: Musenge, Emmanuel Mwila, et al.
Publicado: (2014)

Glycaemic control in diabetes - Bridging the gap
por: Raizada, Nishant, et al.
Publicado: (2020)

The importance of increasing population diversity in genetic studies of type 2 diabetes and related glycaemic traits
por: Barroso, Inês
Publicado: (2021)

Resting metabolic rate in obese diabetic and obese non-diabetic subjects and its relation to glycaemic control
por: Alawad, Azza O, et al.
Publicado: (2013)

Dietary cystine level affects metabolic rate and glycaemic control in adult mice()()
por: Elshorbagy, Amany K., et al.
Publicado: (2012)

Glycaemic control trends in people with type 1 diabetes in Scotland 2004–2016
por: Mair, Colette, et al.
Publicado: (2019)

Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010–2017
por: Dennis, John M., et al.
Publicado: (2019)

Association between depression, glycaemic control and the prevalence of diabetic retinopathy in a diabetic population in Cameroon
por: Hall, Kirsty K., et al.
Publicado: (2017)

The relation of low glycaemic index fruit consumption to glycaemic control and risk factors for coronary heart disease in type 2 diabetes
por: Jenkins, D. J. A., et al.
Publicado: (2010)

Age, body composition parameters and glycaemic control contribute to trabecular bone score deterioration in acromegaly more than disease activity
por: Ságová, Ivana, et al.
Publicado: (2023)

Diabetic patients’ perspectives on the challenges of glycaemic control
por: Adeniyi, Oladele V., et al.
Publicado: (2015)

Effects of glycaemic management on diabetic kidney disease
por: MacIsaac, Richard J, et al.
Publicado: (2017)

Evaluating glycaemic control in patients poorly controlled on oral antidiabetic drugs in real‐world setting: Results from assessing the Appropriate Timing of Type 2 diAbetes INtensification (ATTAIN)
por: Jude, Edward B., et al.
Publicado: (2019)

Food Intake and Dietary Glycaemic Index in Free-Living Adults with and without Type 2 Diabetes Mellitus
por: McGeoch, Susan C., et al.
Publicado: (2011)

Risk of Anemia With Metformin Use in Type 2 Diabetes: A MASTERMIND Study
por: Donnelly, Louise A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ums80oepltjak8p323j1aq2h4k